Kalaris Therapeutics Inc

NASDAQ: KLRS · Real-Time Price · USD
2.46
0.19 (8.37%)
At close: Aug 15, 2025, 3:55 PM
2.42
-1.43%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kalaris Therapeutics Inc Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022
Period Ending Dec 31, 2023 Dec 31, 2022
Net Income
-14.7M -15.48M
Depreciation & Amortization
n/a n/a
Stock-Based Compensation
148K 271K
Other Working Capital
-690K 1.57M
Other Non-Cash Items
1.51M 2.04M
Deferred Income Tax
n/a n/a
Change in Working Capital
-1.09M 3.4M
Operating Cash Flow
-14.13M -9.78M
Capital Expenditures
n/a n/a
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
n/a n/a
Investing Cash Flow
n/a n/a
Debt Repayment
6M 4.3M
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
1.5M 5K
Financial Cash Flow
14.24M 12.78M
Net Cash Flow
110K 3M
Free Cash Flow
-14.13M -9.78M